Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma.

待确认 10 由诗奕发布于 2024/10/26 10:43:29

DOI:10.1007/s11523-023-01029-6
作者：Silvia Camera,?Margherita Rimini,?Federico Rossari,?Toshifumi Tada,?Goki Suda,?Shigeo Shimose,?Masatoshi Kudo,?Changhoon Yoo,?Jaekyung Cheon,?Fabian Finkelmeier,?Ho Yeong Lim,?José Presa,?Gianluca Ma
文献类型：学位论文
补充材料：只需要正文

Springer

Abstract：Background: Data concerning the use of lenvatinib in very old patients (≥ 80 years) are limited, although the incidence of hepatocellular carcinoma (HCC) in this patient population is consta

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

6小时前

yduan

9fcab118934411ef85f034735aa3bc31.pdf

6小时前

Book学术机器人

2024/10/26 10:43:29 未找到该文献，机器人已退出，请等待人工下载

2024/10/26 10:43:29 Book学术AI机器人收到请求，开始寻找文献

2024/10/26 10:43:29 已向机器人发送请求

6小时前

诗奕发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SpringerDevelopment of a New Instrument for Depression With Cognitive Diagnosis Models.